v3.26.1
Consolidated Statements of Shareholders' Equity - USD ($)
Issued capital [member]
Other reserves [member]
Warrant reserves [member]
Convertible loan note reserve [member]
Retained earnings [member]
Translation reserve [member]
Total
Balance at Mar. 31, 2023 $ 131,385,892 $ 3,628,756 $ 82,376 $ (125,697,719) $ (11,452,542) $ (2,053,237)
Balance, shares at Mar. 31, 2023 25,519,774            
IfrsStatementLineItems [Line Items]              
Shares issued for Fundraising, net $ 6,208,508       6,208,508
Shares issued for Fundraising, net, shares 4,159,270            
Expenses settled in shares $ 2,368,287 2,368,287
Expenses settled in shares, shares 1,557,272            
Issuance of shares, related party loan conversion $ 3,150,000 3,150,000
Issuance of shares, related party loan conversion, shares 2,100,000            
Options charge 1,121,273 1,121,273
Options forfeiture (1,419) (1,419)
Warrants charge 11,372 11,372
Total transactions $ 11,726,795 1,119,854 11,372 12,858,021
Total transactions, shares 7,816,542            
Loss for the period (16,825,461) (16,825,461)
Currency translation 141,095 (141,095)
Total comprehensive income (16,825,461) 141,095 (16,684,366)
Proceeds from Convertible loan note            
Balance at Mar. 31, 2024 $ 143,112,687 4,748,610 93,748 (142,523,180) (11,311,447) (5,879,582)
Balance, shares at Mar. 31, 2024 33,336,316            
IfrsStatementLineItems [Line Items]              
Shares issued for Fundraising, net $ 1,705,742 1,705,742
Shares issued for Fundraising, net, shares 1,219,846            
Expenses settled in shares $ 32,302 32,302
Expenses settled in shares, shares 25,842            
Options charge 734,989 734,989
Options forfeiture (4,298,784) 4,204,500 (94,284)
Total transactions $ 3,604,586 (3,563,795) 950,000 4,204,500 5,195,291
Total transactions, shares 2,684,499            
Loss for the period   (4,706,292)   (4,706,292)
Currency translation   (158,973) (158,973)
Total comprehensive income   (4,706,292) (158,973) (4,865,265)
Shares issued in lieu of consultancy fees $ 437,498 437,498
Shares issued in lieu of consultancy fees, shares 300,266            
Shares issued in lieu of Bonus $ 347,500           347,500
Shares issued in lieu of Bonus, shares 250,000            
Shares issued in lieu of interest $ 750,000 750,000
Shares issued in lieu of interest, shares 500,000            
Fees on CLN issuance $ 331,545 331,545
Fees on CLN issuance, shares 388,545            
Proceeds from Convertible loan note 950,000 950,000
Balance at Mar. 31, 2025 $ 146,717,274 1,184,815 93,748 950,000 (143,024,972) (11,470,420) (5,549,555)
Balance, shares at Mar. 31, 2025 36,020,815            
IfrsStatementLineItems [Line Items]              
Shares issued for Fundraising, net $ 25,023,336 25,023,336
Shares issued for Fundraising, net, shares 14,279,388            
Options charge 1,605,259 1,605,259
Options forfeiture (6,130) 3,060 (3,070)
Total transactions $ 26,841,301 1,599,129 (950,000) 3,060 27,493,490
Total transactions, shares 16,458,712            
Loss for the period   (8,949,657)   (8,949,657)
Currency translation   (659,139) (659,139)
Total comprehensive income   (8,949,657) (659,139) (9,608,796)
Shares issued in lieu of consultancy fees $ 321,729 321,729
Shares issued in lieu of consultancy fees, shares 292,018            
Proceeds from Convertible loan note            
CLN settled in Shares $ 950,000 (950,000)
CLN settled in Shares, shares 1,357,143            
CLN Interest settled in shares $ 546,236           546,236
CLN Interest settled in shares, shares 530,163            
Balance at Mar. 31, 2026 $ 173,558,575 $ 2,783,944 $ 93,748 $ (151,971,569) $ (12,129,559) $ 12,335,139
Balance, shares at Mar. 31, 2026 52,479,527